About the Authors
- Matthias Brendel
-
Affiliation Dept. of Nuclear Medicine, University of Munich, Munich, Germany
- Anna Jaworska
-
Affiliations Dept. of Translational Research I, German Center for Neurodegenerative Diseases (DZNE)—site Munich, University of Munich, Munich, Germany, Laboratory of Neurodegeneration, International Institute of Molecular and Cell Biology, Warsaw, Poland
- Eric Grießinger
-
Affiliation Dept. of Translational Research I, German Center for Neurodegenerative Diseases (DZNE)—site Munich, University of Munich, Munich, Germany
- Christina Rötzer
-
Affiliation Dept. of Nuclear Medicine, University of Munich, Munich, Germany
- Steffen Burgold
-
Affiliation Dept. of Translational Research I, German Center for Neurodegenerative Diseases (DZNE)—site Munich, University of Munich, Munich, Germany
- Franz-Josef Gildehaus
-
Affiliation Dept. of Nuclear Medicine, University of Munich, Munich, Germany
- Janette Carlsen
-
Affiliation Dept. of Nuclear Medicine, University of Munich, Munich, Germany
- Paul Cumming
-
Affiliations Department of Nuclear Medicine, University of Erlangen, Erlangen, Germany, Department of Neuroscience and Pharmacology, Copenhagen University, Copenhagen, Denmark
- Karlheinz Baumann
-
Affiliation F. Hoffmann-La Roche, Basel, Switzerland
- Christian Haass
-
Affiliations Adolf-Butenandt-Institute, Biochemistry, University of Munich, Munich, Germany, DZNE–German Center for Neurodegenerative Diseases, Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- Harald Steiner
-
Affiliations Adolf-Butenandt-Institute, Biochemistry, University of Munich, Munich, Germany, DZNE–German Center for Neurodegenerative Diseases, Munich, Germany
- Peter Bartenstein
-
Affiliations Dept. of Nuclear Medicine, University of Munich, Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- Jochen Herms
-
Affiliations Dept. of Translational Research I, German Center for Neurodegenerative Diseases (DZNE)—site Munich, University of Munich, Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- Axel Rominger
-
* E-mail: axel.rominger@med.uni-muenchen.de
Affiliations Dept. of Nuclear Medicine, University of Munich, Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
Competing Interests
M. B. reports no disclosures; A. J. reports no disclosures; E. G. reports no disclosures; C. R. reports no disclosures; S. B. reports no disclosures; F. G. reports no disclosures; J. C. reports no disclosures; P. C. reports no disclosures; K. B. is an employee of F. Hoffmann-La Roche; C. H. reports no disclosures; H. S. reports no disclosures; P. B. received consultant fees from GE and Piramal Imaging, and honoraria from Siemens; J. H. reports no disclosures; A. R. received consultant fees from Piramal Imaging and GE. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: AR JH PB HS CH. Performed the experiments: MB AJ EG CR SB. Analyzed the data: MB AJ EG CR SB. Contributed reagents/materials/analysis tools: FG JC KB. Wrote the paper: MB AJ PC AR.